Withdrawal Notice
This paper was originally published in Oncotarget Advance Online Publications on 12/30/2017.In compliance with Oncotarget's withdrawal policy, the paper was withdrawn in its entirety. It will not appear in Oncotarget internal or any external indexes or archives.
Research Papers:
Mouse Trefoil Factor 3 (Tff3) Ameliorates Fatty Liver Phenotype via Increasing Peroxisome Proliferator-activated Receptor-α (PPARα) Expression
Xiaojie Wu1,*, Haiyong Jin2,*,Yueling Zhang3, Mingyuan Dong3, Xiaoting Wu3, Jiadi Zhou1, Weishan Zhuge4, Jianjing Yang5, Qichuan Zhuge5, Xiying Luan1, Dexiang Ban6, Wenjie Zhu3, Yongjun Jin7 and Jiangnan Xue1
1 Department of Immunology, Binzhou Medical University, Yantai, China
2 Department of Otorhinolaryngology, The Second Affiliated Hospital& Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou, China
3 Department of Operating Theatre, Binzhou People’s Hospital, Binzhou, China
4 Department of Gastrointestinal Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
5 Department of Neurosurgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
6 Department of Orthopaedics, Tianjin Medical University General Hospital, Tianjin,China
7 Department of Endocrinology, Yantai affiliate hospital, Binzhou Medical University, Yantai, China
* Xiaojie Wu and Haiyong Jin contributed equally to this work
Correspondence to:
Jiangnan Xue, email: [email protected]
Yongjun Jin, email: [email protected]
Keywords: nonalcoholic fatty liver disease; mouse trefoil factor 3; peroxisome proliferator- activated receptor-α; fatty acid oxidation; lipogenesis
Received: March 03, 2017 Accepted: December 13, 2017 Epub: December 30, 2017

PII: 23780